🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Vcap(s) Serving Size
120 Servings
Vitamin Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin C
2 mg (2% DV)
100 mcg (83% DV)
✅ Within RDA (0.8× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.1mg

Other Ingredients

Cellulose Silica Vegetable Magnesium Stearate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take one (1) capsule daily with a meal or as directed by your qualified healthcare professional.

⚠️ Warnings & Precautions

Keep out of the reach of children.

Do not use if safety seal is broken or missing.

Caution: For adults only, if you are pregnant, nursing, taking any medications (especially anticoagulants [e.g. Warfarin/Coumadin]), or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

🧪 Formulation Notes

MK-7 is made via fermentation by bacillus licheniformis. MK-7 (Menaquinone-7), an enhanced bioactive form of vitamin K2, is ten times better absorbed than vitamin K1 from spinach. Certain research publications indicate that MK-7 may help support the following: Supports healthy bones. Supports healthy cardiovascular function. Supports healthy aging.

MenaQ7 Vitamin K2 as MK-7

3rd party lab tested

No artificial color, flavor or sweetener, no preservatives, no sugar, no starch, no milk, no corn, no egg, no lactose, no gluten, no wheat, no fish. Sodium free.

Additional Information

Keep in cool, dry place.

Made in USA

GMP Good Manufacturing Practice Product

For additional information call 1-877-659-6004

Product Details

UPC / SKU 8 17716 01142 4
DSLD Entry Date 2022-09-22
Product Type Vitamin
Form Capsule
DSLD ID 272179
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →